How Many Metastases Rule Out Ablation?

Dr. David Kerr reports on a study fueling the controversy about which CRC patients with unresectable liver mets who receive conversion chemotherapy are candidates for secondary resection or ablation.

Source: Medscape General Surgery Podcast - June 27, 2014 Category: Surgery Authors: Medscape Source Type: podcasts